Filters








1 Hit in 0.038 sec

Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies

G. Zugmaier, M. Klinger, M. Schmidt, M. Subklewe, K. I. Kirgizov, T. V. Shamanskaya
2016 Russian Journal of Children Hematology and Oncology  
doi:10.17650/2311-1267-2016-3-2-18-30 fatcat:nxae7rdxancbta55vroepgsxli